Xiao Y[au] - Search Results

Year	Number of Results
1980	1
1981	3
1982	2
1983	7
1984	4
1985	5
1986	7
1987	6
1988	3
1989	8
1990	7
1991	8
1992	5
1993	12
1994	16
1995	27
1996	24
1997	29
1998	39
1999	53
2000	72
2001	64
2002	69
2003	96
2004	138
2005	182
2006	195
2007	240
2008	289
2009	325
2010	401
2011	480
2012	555
2013	644
2014	783
2015	846
2016	962
2017	1035
2018	1305
2019	1600
2020	1845
2021	2117
2022	916

1

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Huang C, et al. Among authors: xiao y. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986264 Free PMC article.

2

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.

Wang Y, Chen L, Ju L, Qian K, Liu X, Wang X, Xiao Y. Wang Y, et al. Among authors: xiao y. Front Oncol. 2019 Oct 11;9:1030. doi: 10.3389/fonc.2019.01030. eCollection 2019. Front Oncol. 2019. PMID: 31681575 Free PMC article.

3

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.

Xiao Y, Najeeb RM, Ma D, Yang K, Zhong Q, Liu Q. Xiao Y, et al. J Exp Clin Cancer Res. 2019 Nov 8;38(1):458. doi: 10.1186/s13046-019-1444-0. J Exp Clin Cancer Res. 2019. PMID: 31703591 Free PMC article.

4

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.

Tang J, Tu S, Lin G, Guo H, Yan C, Liu Q, Huang L, Tang N, Xiao Y, Pope RM, Rajaram MVS, Amer AO, Ahmer BM, Gunn JS, Wozniak DJ, Tao L, Coppola V, Zhang L, Langdon WY, Torrelles JB, Lipkowitz S, Zhang J. Tang J, et al. Among authors: xiao y. J Exp Med. 2020 Apr 6;217(4):e20182091. doi: 10.1084/jem.20182091. J Exp Med. 2020. PMID: 31999304 Free PMC article.

5

Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.

Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L. Ye L, et al. Among authors: xiao y. EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28. EMBO Mol Med. 2019. PMID: 31657150 Free PMC article.

6

Sleep duration, midday napping, and sleep quality and incident stroke: The Dongfeng-Tongji cohort.

Zhou L, Yu K, Yang L, Wang H, Xiao Y, Qiu G, Liu X, Yuan Y, Bai Y, Li X, Yang H, He M, Wang C, Wu T, Zhang X. Zhou L, et al. Among authors: xiao y. Neurology. 2020 Jan 28;94(4):e345-e356. doi: 10.1212/WNL.0000000000008739. Epub 2019 Dec 11. Neurology. 2020. PMID: 31827003

7

Tripterygium and its extracts for diabetic nephropathy: Efficacy and pharmacological mechanisms.

Huang WJ, Liu WJ, Xiao YH, Zheng HJ, Xiao Y, Jia Q, Jiang HX, Zhu ZB, Xia CH, Han XT, Sun RX, Nan H, Feng ZD, Wang SD, Zhao JX. Huang WJ, et al. Among authors: xiao yh, xiao y. Biomed Pharmacother. 2020 Jan;121:109599. doi: 10.1016/j.biopha.2019.109599. Epub 2019 Nov 7. Biomed Pharmacother. 2020. PMID: 31707345 Free article. Review.

8

CD38 Deficiency Alleviates D-Galactose-Induced Myocardial Cell Senescence Through NAD⁺/Sirt1 Signaling Pathway.

Wang LF, Cao Q, Wen K, Xiao YF, Chen TT, Guan XH, Liu Y, Zuo L, Qian YS, Deng KY, Xin HB. Wang LF, et al. Among authors: xiao yf. Front Physiol. 2019 Sep 3;10:1125. doi: 10.3389/fphys.2019.01125. eCollection 2019. Front Physiol. 2019. PMID: 31551807 Free PMC article.

9

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.

Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L. Wang N, et al. Among authors: xiao y. Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017. Blood. 2020. PMID: 31697824 Free article. Clinical Trial.

10

Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition.

Kong N, Tao W, Ling X, Wang J, Xiao Y, Shi S, Ji X, Shajii A, Gan ST, Kim NY, Duda DG, Xie T, Farokhzad OC, Shi J. Kong N, et al. Among authors: xiao y. Sci Transl Med. 2019 Dec 18;11(523):eaaw1565. doi: 10.1126/scitranslmed.aaw1565. Sci Transl Med. 2019. PMID: 31852795 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results